Brain aging patterns in a large and diverse cohort of 49,482 individuals.
Zhijian YangJunhao WenGuray ErusSindhuja T GovindarajanRanda MelhemElizabeth MamourianYuhan CuiDhivya SrinivasanAhmed AbdulkadirParaskevi ParmpiKatharina WittfeldHans J GrabeRobin BülowStefan FrenzelDuygu TosunMurat BilgelYang AnDahyun YiDaniel S MarcusPamela LaMontagneTammie L S BenzingerSusan R HeckbertThomas R AustinShari R WaldsteinMichele K EvansAlan B ZondermanLenore J LaunerAristeidis SotirasMark A EspelandColin L MastersPaul MaruffJurgen FrippArthur W TogaSid O'BryantM Mallar ChakravartySylvia VilleneuveSterling C JohnsonJohn C MorrisMarilyn S AlbertKristine YaffeHenry VölzkeLuigi FerruciR Nick BryanRussell T ShinoharaYong FanMohamad HabesParis Alexandros LalousisNikolaos KoutsoulerisDavid A WolkSusan M ResnickHaochang ShouIlya M NasrallahChristos DavatzikosPublished in: Nature medicine (2024)
Brain aging process is influenced by various lifestyle, environmental and genetic factors, as well as by age-related and often coexisting pathologies. Magnetic resonance imaging and artificial intelligence methods have been instrumental in understanding neuroanatomical changes that occur during aging. Large, diverse population studies enable identifying comprehensive and representative brain change patterns resulting from distinct but overlapping pathological and biological factors, revealing intersections and heterogeneity in affected brain regions and clinical phenotypes. Herein, we leverage a state-of-the-art deep-representation learning method, Surreal-GAN, and present methodological advances and extensive experimental results elucidating brain aging heterogeneity in a cohort of 49,482 individuals from 11 studies. Five dominant patterns of brain atrophy were identified and quantified for each individual by respective measures, R-indices. Their associations with biomedical, lifestyle and genetic factors provide insights into the etiology of observed variances, suggesting their potential as brain endophenotypes for genetic and lifestyle risks. Furthermore, baseline R-indices predict disease progression and mortality, capturing early changes as supplementary prognostic markers. These R-indices establish a dimensional approach to measuring aging trajectories and related brain changes. They hold promise for precise diagnostics, especially at preclinical stages, facilitating personalized patient management and targeted clinical trial recruitment based on specific brain endophenotypic expression and prognosis.
Keyphrases
- resting state
- white matter
- magnetic resonance imaging
- functional connectivity
- clinical trial
- artificial intelligence
- metabolic syndrome
- cerebral ischemia
- physical activity
- cardiovascular disease
- machine learning
- stem cells
- randomized controlled trial
- computed tomography
- type diabetes
- long non coding rna
- magnetic resonance
- case report
- weight loss
- big data
- cardiovascular events
- study protocol
- drug delivery
- copy number
- bone marrow
- double blind
- cross sectional
- cancer therapy
- mesenchymal stem cells